• Value Research Rating market-capitalisation-info
    Not Applicable
  • Market Capitalisation market-capitalisation-info $57 Mln
  • Price to Earnings Ratio price-to-earning --
  • 12 Month Earnings monthly-earning $-14 Mln

InspireMD Inc. (NSPR) Share Price

$2.61

As on 20-Feb-2024 15:59 EST

up-down-arrow $-0.04-1.32%

  • Prev Close info

    $2.65

  • Day's Openinfo

    $2.64

  • Today's Highinfo

    $2.65

  • Today's Lowinfo

    $2.61

  • Today's Volumeinfo

    7,323

  • 52 Week rangeinfo

    $0.96 - 3.85

Please wait...

InspireMD Inc. (NSPR) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
InspireMD (NSPR)
-7.12 -15.81 -10.31 102.33 -47.32 -54.83 -72.35
S&P BSE Sensex*
0.53 1.68 10.61 19.66 12.59 15.22 13.46
S&P Small-Cap 600#
-5.82 -5.34 -13.73 -6.30 5.30 2.98 5.53
As on 20-Feb-2024  |  *As on 21-Feb-2024  |  #As on 26-Oct-2023
2023
2022
2021
2020
2019
2018
2017
InspireMD (NSPR)
226.93 -71.52 -40.78 -68.52 -86.50 22.94 -94.80
S&P Small-Cap 600
13.89 -17.42 25.27 9.57 20.86 -9.70 11.73
S&P BSE Sensex
18.74 4.44 21.99 15.75 14.38 5.87 27.91

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

InspireMD Inc. (NSPR) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of InspireMD Inc. (NSPR)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other details of InspireMD Inc. (NSPR)

        President, CEO & Director

        Mr. Marvin L. Slosman

        CFO, Chief Administrative Officer, Secretary & Treasurer

        Mr. Craig Shore

        Headquarters

        Tel Aviv

        FAQs for InspireMD Inc. (NSPR)

        The total asset value of InspireMD Inc. (NSPR) stood at $ 55 Mln as on 30-Sep-23

        The share price of InspireMD Inc. (NSPR) is $2.61 (NASDAQ) as of 20-Feb-2024 15:59 EST. InspireMD Inc. (NSPR) has given a return of -47.32% in the last 3 years.

        InspireMD Inc. (NSPR) has a market capitalisation of $ 57 Mln as on 16-Feb-2024. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of InspireMD Inc. (NSPR) is 1.32 times as on 16-Feb-2024, a -0.67% premium to its peers’ median range of 4.02 times.

        Since, TTM earnings of InspireMD Inc. (NSPR) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the InspireMD Inc. (NSPR) and enter the required number of quantities and click on buy to purchase the shares of InspireMD Inc. (NSPR).

        InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel. Address: 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832

        The CEO & director of Mr. Marvin L. Slosman. is InspireMD Inc. (NSPR), and CFO & Sr. VP is Mr. Craig Shore.

        The promoters of InspireMD Inc. (NSPR) have pledged 0% of the total equity as on Sep-23.

        InspireMD Inc. (NSPR) Ratios
        Return on equity(%)
        -67.85
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0

        No, TTM profit after tax of InspireMD Inc. (NSPR) was $-14 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $57.00 Mln
        • Revenue (TTM)revenue-information $5.47 Mln
        • Earnings (TTM) earning-information $-14.18 Mln
        • Cash date-information $43.03 Mln
        • Total Debt info $1.06 Mln
        • Insider's Holding 21.92%
        • Liquidity liquidity High
        • 52 Week range week-range $0.96 - 3.85
        • Shares outstanding share-outstanding 21,549,600
        • 10 Years Aggregate:

          CFO: $-112.13 Mln

          EBITDA: $-126.76 Mln

          Net Profit: $-148.07 Mln

        About The Company

        • IPO Date 12-Apr-2011
        • President, CEO & Director Mr. Marvin L. Slosman
        • CFO, Chief Administrative Officer, Secretary & Treasurer Mr. Craig Shore
        • Listing key-listing NASDAQ: NSPR
        • Country Israel
        • Headquarters headquarters Tel Aviv
        • Website website https://www.inspiremd.com
        • Business

          InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The...  company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel. Address: 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832  Read more

        share-fund-plan-icon